Global High-Density Multiplexed Diagnostic Assays Market to Reach $4.9 Billion by 2030
The global market for High-Density Multiplexed Diagnostic Assays estimated at US$1.6 Billion in the year 2022, is projected to reach a revised size of US$4.9 Billion by 2030, growing at a CAGR of 14.8% over the analysis period 2022-2030. Diagnostic Laboratories, one of the segments analyzed in the report, is projected to record 15.2% CAGR and reach US$1.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Hospitals & Clinics segment is readjusted to a revised 14.6% CAGR for the next 8-year period.The U.S. Market is Estimated at $474 Million, While China is Forecast to Grow at 13.8% CAGR
The High-Density Multiplexed Diagnostic Assays market in the U.S. is estimated at US$474 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$819.1 Million by the year 2030 trailing a CAGR of 13.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.5% and 12.6% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 10.5% CAGR.Select Competitors (Total 12 Featured) -
- Abbott Laboratories
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Erba Diagnostics, Inc.
- F. Hoffmann-La Roche AG
- Gold Standard Diagnostics Corporation
- Hologic, Inc.
- Luminex Corporation
- Randox Laboratories Ltd.
- Thermo Fisher Scientific, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
REST OF EUROPE
ASIA-PACIFIC
REST OF WORLD
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- Erba Diagnostics, Inc.
- F. Hoffmann-La Roche AG
- Gold Standard Diagnostics Corporation
- Hologic, Inc.
- Luminex Corporation
- Randox Laboratories Ltd.
- Thermo Fisher Scientific, Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 158 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 1.6 Billion |
Forecasted Market Value ( USD | $ 4.9 Billion |
Compound Annual Growth Rate | 15.0% |
Regions Covered | Global |